CHMP recommends EU approval of Actemra/RoActemra to treat patients with severe COVID-19

NEXT STORY
Surface Oncology Presents Promising Clinical Data on SRF617 at the European Society for Medical Oncology Immuno-Oncology Congress (ESMO-IO) 2021
PREV STORY
Atossa Therapeutics Completes Pre-IND Meeting with U.S. Food & Drug Administration
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science is providing a summary of the live webcast held on 06 March 2020 with key opinion leaders in progressive forms of multiple sclerosis

author_avatar
NASDAQ Market News

Medical Equipment Financing Market to cross USD 205 Bn by 2026: Global Market Insights, Inc.

author_avatar
NASDAQ Market News

Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News